UK's approval of casgevy paves the way for gene-edited treatment of blood disorders
BBC - 16-Nov-2023Casgevy offers hope for patients with sickle cell disease and beta thalassemia
Join the club for FREE to access the whole archive and other member benefits.
Regulates medicines, medical devices and blood components for transfusion in the UK
(MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.
The MHRA has several independent advisory committees which provide the UK Government with information and guidance on the regulation of medicines and medical devices. There are currently eight such committees.
The MHRA manages the Early Access to Medicines Scheme (EAMS), which was created in 2014 to allow access to medicines prior to market authorisation where there is a clear unmet medical need.
Visit website: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
medicines-and-healthcare-products-regulatory-agency
Details last updated 30-Apr-2022
Chief Science, Research and Innovation Officer at Medicines and Healthcare products Regulatory Agency (MHRA)
Casgevy offers hope for patients with sickle cell disease and beta thalassemia
The drug works by regulating appetite and reducing cravings
More research is needed to confirm the health benefits of mushrooms
Fully automated Intelligent Cell Processing System to manufacture potentially life-saving treatments
Ongoing clinical trials for heart patients with cellular therapy to cure damaged heart muscles
GenSight using gene therapy and a wearable device to restore sight in patients with retinitis pig...